Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2024 | Sionna Therapeutics | $180.0M Series C | Edd Fleming | Atlas Venture, OrbiMed, Third Rock Ventures, Cystic Fibrosis Foundation, Perceptive Advisors, RA Capital Management, Michael Cloonan, TPG, T. Rowe Price Associates, Viking Global Investors |
| Apr 1, 2022 | Sionna Therapeutics | $110.0M Series B | OrbiMed | Atlas Venture, Third Rock Ventures, Michael Boyle, Joshua Resnick, Lucian Iancovici, T. Rowe Price Associates |